Polymerase News and Research

RSS
SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

Plasmonic sensing of isothermally amplified nucleic acids and single-molecule detection of SARS-CoV-2

Plasmonic sensing of isothermally amplified nucleic acids and single-molecule detection of SARS-CoV-2

Acquisition of Advanced Diagnostic Laboratory LLC

Acquisition of Advanced Diagnostic Laboratory LLC

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Study shows an association between initial SARS-CoV-2 viral load and disease severity

Study shows an association between initial SARS-CoV-2 viral load and disease severity

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

SARS-CoV-2 evolution promoted by long-term infection in patient with B cell depletion

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

Graphene biosensor in a portable and wireless device for rapid SARS-CoV-2 detection

Enisamium shows potential as antiviral therapy for COVID-19

Enisamium shows potential as antiviral therapy for COVID-19

Rapid molecular assay to detect SARS-CoV-2-specific RNA sequences

Rapid molecular assay to detect SARS-CoV-2-specific RNA sequences

Transmission of SARS-CoV-2 during a 2-hour domestic flight

Transmission of SARS-CoV-2 during a 2-hour domestic flight

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

Anti-nucleocapsid SARS-Cov-2 antibodies wane over time in long-term care facilities

Anti-nucleocapsid SARS-Cov-2 antibodies wane over time in long-term care facilities

What makes SARS-CoV-2 variants more virulent?

What makes SARS-CoV-2 variants more virulent?

Using nasopharyngeal microbiota as early biomarker in patients with COVID-19

Using nasopharyngeal microbiota as early biomarker in patients with COVID-19

Children are less likely to get long-COVID, yet still at risk, study finds

Children are less likely to get long-COVID, yet still at risk, study finds

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

A covid test costing more than a Tesla? It happened in Texas.

A covid test costing more than a Tesla? It happened in Texas.

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Aging may not be due to build-up of mutations alone, study suggests

Aging may not be due to build-up of mutations alone, study suggests

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.